Catalyst Wire Dossier Catalyst Wire Dossier

RSV vaccine, adjuvanted

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RSV vaccine, adjuvanted, covering 2021-08-26 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant [Phase 2]

See pricing